Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Infection and AFP[original query] |
---|
Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy. Transplantation 2012 Mar 93 (6): 644-9. Eurich Dennis, Boas-Knoop Sabine, Bahra Marcus, Neuhaus Ruth, Somasundaram Rajan, Neuhaus Peter, Neumann Ulf, Seehofer Dani |
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C. Journal of gastroenterology 2014 Jul 49 (7): 1152-62. Asahina Yasuhiro, Tsuchiya Kaoru, Nishimura Takashi, Muraoka Masaru, Suzuki Yuichiro, Tamaki Nobuharu, Yasui Yutaka, Hosokawa Takanori, Ueda Ken, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Kurosaki Masayuki, Enomoto Nobuyuki, Nakagawa Mina, Kakinuma Sei, Watanabe Mamoru, Izumi Nami |
Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection. World journal of hepatology 2013 Mar 5 (3): 97-103. Omran Moataza H, Fotouh Basma E, Youssef Samar S, Ibrahim Noha E, Nabil Wael, Mahdy El-Sayed M, Shosha Wafaa G, El-Awady Mostafa |
No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. PloS one 2013 8 (12): e81312. Nakamura Masato, Kanda Tatsuo, Nakamoto Shingo, Miyamura Tatsuo, Jiang Xia, Wu Shuang, Yokosuka Osa |
IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV. Asian Pacific journal of cancer prevention : APJCP 2014 15 (17): 7213-8. Zekri Abdel-Rahman N, Salama Hosny, Medhat Eman, Bahnassy Abeer A, Morsy Heba M, Lotfy Mai M, Ahmed Rasha, Darwish Tarneem, Marei Mohamad |
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population. Journal of the renin-angiotensin-aldosterone system : JRAAS 2015 Sep 16 (3): 695-9. Zha Yong, Gan Ping, Liu Qin, Tan Ji |
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015 May 13 (5): 1017-24. Chang Kuo-Chin, Tseng Po-Lin, Wu Yi-Ying, Hung Hung-Chao, Huang Chao-Min, Lu Sheng-Nan, Wang Jing-Houng, Lee Chuan-Mo, Chen Chien-Hung, Tsai Ming-Chao, Yen Yi-Hao, Lin Ming-Tsung, Wu Cheng-Kun, Huang Chao-Cheng, Chen Hsiu-Hsi, Hu Tsung-H |
Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt. Molecular biology reports 2014 Mar 41 (3): 1461-8. Mohamed Faten Zahran, Hussein Yousry Mostafa, El-Deen Ibrahim Mohey, Sabea Marwa Say |
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget 2016 Apr . Yang Xunjun, Guo Xiuchan, Chen Yao, Chen Guorong, Ma Yin, Huang Kate, Zhang Yuning, Zhao Qiongya, Winkler Cheryl A, An Ping, Lyu Jianx |
Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma. Genetics and molecular research : GMR 2015 14 (4): 17453-62. Yvamoto E Y, Ferreira R F, Nogueira V, Pinhe M A S, Tenani G D, Andrade J G S C, Baitello M E L, Gregório M L, Fucuta P S, Silva R F, Souza D R S, Silva R C M |
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection. Journal of gastroenterology 2018 3 53 (9): 1089-1097. Akuta Norio, Toyota Joji, Karino Yoshiyasu, Ikeda Fusao, Ido Akio, Tanaka Katsuaki, Takaguchi Koichi, Naganuma Atsushi, Tomita Eiichi, Chayama Kazuaki, Fujiyama Shigetoshi, Inada Yukiko, Yoshiji Hitoshi, Watanabe Hideaki, Ishikawa Hiroki, McPhee Fiona, Noviello Stephanie, Kumada Hiromit |
TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. British journal of biomedical science 2019 Jan 76 (1): 35-41. Sghaier I, Zidi S, Mouelhi L, Ghazoueni E, Brochot E, Almawi W Y, Loueslati B |
Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis. British journal of biomedical science 2019 Nov . Raafat Rowida I, Eshra K A, El-Sharaby R M, Eissa Rae, Saied S M, Amer I, El Sharawy |
Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma. Immunologic research 2020 Jun . Abd El-Baky Reham M, Hetta Helal F, Koneru Gopala, Ammar Marwa, Shafik Engy A, Mohareb Dina A, Abbas El-Masry Muhammad, Ramadan Haidi K, Abu Rahma Mohamed Zakaria, Fawzy Michael A, Fathy Mousta |
A Clinicopathological Study of Young-onset Hepatocellular Carcinoma. Anticancer research 2021 6 41 (6): 2933-2944. Au Kwan-Yung, Chan Kristy Kwan-Shuen, Lo Regina Cheuk-L |
Genotype Distribution of Vitamin D Receptor Polymorphisms among Indonesian Patients with Chronic Hepatitis B. Reports of biochemistry & molecular biology 2021 5 9 (4): 463-469. Arfianti Arfianti, Sabillah Sumpena Athalah, Andrini Djojosugito Fauzia, Kartika Sari Dita, Julia Paulina Ari |
Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt. Asian Pacific journal of cancer prevention : APJCP 2023 12 24 (12): 4253-4261. Amal El Sharnoby, Hanan M Bedair, Gamal Yousef S Raia, Nermeen Hamed, Aliaa Sabry, Fatma A Khalaf, Mohamed Rashed Abd Elhamed, Mohamed Abdel-Sami |
- Page last reviewed:Feb 1, 2024
- Content source: